Bench Press: BioWorld Looks at Translational Medicine
Monday, November 19, 2012
Scientists from the National Cancer Institute have found that PARP inhibitors work through other mechanisms in addition to inhibiting the repair of DNA breaks.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.